Clinical trial

NexGen TM Tibia Clinical Outcomes Study

NCT03272373

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-10-03

PhaseNA

Study timeline

Study start (actual)2017-10-03Date precision: day

Registry last updated2024-12-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Osteoarthritisunresolved

Rheumatoid Arthritisunresolved

Traumatic Arthritisunresolved

Polyarthritisunresolved

Collagen Disorders and/or Avascular Necrosis of the Femoral Condyleunresolved

Post-traumatic Loss of Joint Configurationunresolved

Moderate Valgus, Varus, or Flexion Deformitiesunresolved

Interventions

NexGen TM Monoblock TibiaDEVICE

NexGen TM Modular TibiaDEVICE

Sponsors & collaborators

Zimmer Biometlead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1 TorranceCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03272373 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.